<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00534547</url>
  </required_header>
  <id_info>
    <org_study_id>AS07009</org_study_id>
    <nct_id>NCT00534547</nct_id>
  </id_info>
  <brief_title>Duodenal Exclusion for the Treatment of Type 2 Diabetes</brief_title>
  <official_title>Phase IV Study of Duodenal Exclusion for the Treatment of Type 2 Diabetes (T2DM)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic - MITG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the role of an experimental surgery that may
      offer better short and long-term control of T2DM in select patients who have not achieved
      adequate blood sugar control with regular means.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    business reasons
  </why_stopped>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment success based on patients' glycemic control</measure>
    <time_frame>12 Months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physiologic Measurements, Comorbidity improvement, Improvement in QOL</measure>
    <time_frame>12 Months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Diabetes</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Duodenal Exclusion</intervention_name>
    <description>duodenal-jejunal bypass</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Age between 20 and 50 years old;

          -  BMI between 27 and 34.9;

          -  Oral agents or insulin to control T2DM;

          -  Inadequate control of diabetes as defined as HbA1c&gt;8.0% but &lt;10%

          -  Understanding of the mechanisms of action of the treatment

        Exclusion criteria:

          -  More than 5 years of T2DM diagnosis;

          -  C-peptide &lt;1pg/ml (off insulin)

          -  Previous abdominal operations;

          -  History of gastritis

          -  History of GERD

          -  History of peptic ulcer disease

          -  Inflammatory bowel disease

          -  Coagulopathy;

          -  Liver cirrhosis;

          -  Unable to comply with study requirements, follow-up schedule or give valid informed
             consent;

          -  Currently pregnant (pregnancy test required for confirmation for those of child
             bearing years)

          -  Patient is not available for programmed follow-up during the study period

          -  Patient is unwilling to forgo good samaritan blood donation during the study period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Noreen Fahey</last_name>
    <role>Study Director</role>
    <affiliation>Medtronic - MITG</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 24, 2007</study_first_submitted>
  <study_first_submitted_qc>September 24, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2007</study_first_posted>
  <last_update_submitted>July 23, 2015</last_update_submitted>
  <last_update_submitted_qc>July 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

